Self-Help Interventions for Crohn's Disease
(EMPOWER-IBD Trial)
Trial Summary
What is the purpose of this trial?
EMPOWER-IBD aims to identify behavioral interventions to strengthen patients' self-efficacy for self-management as a mechanism to reduce IBD-related disability. This multisite, randomized controlled trial with 16 arms will randomize adults with moderate-to-severe IBD-related disability to a combination of four multimodal behavioral interventions to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy. The interventions are four existing, publicly available disease-specific self-help resources offered at no cost to the participants: a book, smart app, help center, and peer mentor. Participants will complete online surveys and may engage in virtual focus groups. Participants may receive an honorarium (e-gift card) and/or be entered into a lottery for a giftcards post-survey completion and focus group participation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on self-help resources rather than medication changes.
What data supports the effectiveness of the treatment EMPOWER-IBD Interventions for Crohn's Disease?
Research shows that self-management techniques, which are part of the EMPOWER-IBD Interventions, can lead to better symptom control and improved well-being for people with inflammatory bowel disease (IBD). Studies have found that when patients are more confident in managing their condition, they often experience better health outcomes.12345
Is the self-help intervention for Crohn's Disease safe for humans?
How is the EMPOWER-IBD treatment different from other treatments for Crohn's Disease?
The EMPOWER-IBD treatment is unique because it focuses on self-help and self-management techniques, which empower patients to manage their symptoms and improve their quality of life, rather than relying solely on medication. This approach is supported by evidence suggesting that self-management can lead to better outcomes in symptom control and psychological well-being.13456
Eligibility Criteria
This trial is for adults over 18 with moderate-to-severe IBD-related disability (score > 35). Participants must be able to consent, complete surveys, and join focus groups in English. It's not for those with low/no disability, unwilling to engage in interventions or unable to download apps due to language limitations.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to one of 16 arms to receive a combination of four multimodal behavioral interventions, including a book, smart app, help center, and peer mentor, to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy.
Follow-up
Participants are monitored for changes in IBD self-efficacy and IBD-related disability after the intervention.
Treatment Details
Interventions
- EMPOWER-IBD Interventions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor